|
|
|
|
|
by James_K
902 days ago
|
|
> FSL could try is to "reclaim" "source-available" All the adults in the room realise that "source available" is just an accurate descriptor for what they do, but sentry won't accept anything without the term "open source" in it. They view themselves as open source and the fact that they don't use an open source license is merely an incidental thing they do to deal with some of the challenges of being open source. Instead of admitting their position, they seek to change the definition of open source to match what they are doing. > The best advice I can give to people embroiled in one is to care less about "technically category X" if at all possible. I think there is nothing technical about FSL being source available. Open source is about being communally built and communally owned. Everyone contributes and everyone is free to profit. By contrast, this is a license where everyone is free to contribute but only the owner is free to profit. The only difference is that two years after the owner stops profiting, the software opens up to everyone else. Source available is honestly better for everyone than closed source, and sometimes even better than open source. The only really bad thing you can do is use a source available license while misleading people into thinking you're open source, because you are taking their work under false pretence. https://open.sentry.io/ |
|
Note that I used "technically" as the opposite of "typically". My suggestion is to care less about being in a category you don't want to be in when you are different from its representative members where it matters to you. (In this case the category is source-available licenses.) Focus your advocacy on how you differ instead of arguing membership. ("Yes, we are a source-available license. Don't let it turn you away. There are critical differences between us and source-available licenses you don't like. We are better than old read-only and new Commons-Clause licenses because..."—not literally this, but that's the idea.)